MONTREAL–(BUSINESS WIRE)–“This research project, benefiting from a budget of $2.2 million, one of six jointly supported by Genome Canada and Génome Québec, aims to set up a high-throughput platform integrating genetic transformation, multi-omics analyses, and phenotype detection through hyperspectral imaging, using artificial intelligence, allowing for accelerated selection of clonal plant lines,” says Dr. Davoud Torkamaneh, … [Read more…]

SYDNEY–(BUSINESS WIRE)–#ArtificialIntelligence–Integrant, a pioneering Australian biotechnology company, proudly announced today that it has officially been granted the Nasdaq ticker symbol **INGT**. This milestone facilitates the company’s highly anticipated Initial Public Offering (IPO) on the Nasdaq Stock Market, positioning Integrant as a global leader in AI-enhanced regenerative medicine. Established in Sydney, Integrant specialises in the seamless … [Read more…]

VANCOUVER, British Columbia & GRAPEVINE, Texas–(BUSINESS WIRE)–Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that on April 14, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to … [Read more…]

TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align has again been recognized, for the fifth consecutive year, as a Top 100 Global … [Read more…]

Decision reinforces workplace safety obligations for companies and contractors on-site MILWAUKEE–(BUSINESS WIRE)–The Wisconsin Supreme Court has affirmed that Pabst Brewing Co. can be held liable for asbestos exposure at its Milwaukee brewery, marking the latest development in long-running litigation brought by the family of a steamfitter who died from mesothelioma. The case was decided in … [Read more…]

BOCA RATON, Fla.–(BUSINESS WIRE)–$ISRG #FDAcleared–SurGenTec, LLC, a leader in innovative spine and orthopedic technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its TiLink™ Navigation Instruments for use with the TiLink™ SI Joint Fusion System in sacroiliac joint procedures. The system is engineered for compatibility with Medtronic’s StealthStation™ … [Read more…]

Unit-dose, alcohol-free formulation designed to support precise dosing and ease of administration across pediatric, geriatric, dysphagic, and institutional care settings FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–#amlodipine—Pangea Pharmaceuticals, a U.S.-based, patient-centered pharmaceutical company focused on bringing differentiated, clinically relevant products to market, today announced the U.S. launch of Sdamlo™ (amlodipine for oral solution), the first and only FDA-approved, … [Read more…]

– Today, Alloy has over 200 partners with over 100 licensed therapeutic programs, including 22 in clinical development – Powered by AI integrated with real-world data and wet lab execution, Alloy delivers a faster, more capital-efficient path from idea to clinic BOSTON–(BUSINESS WIRE)–Alloy Therapeutics, Inc. (“Alloy”), a biotechnology ecosystem company powering the future of drug … [Read more…]

Grindr for Equality Presents: Out in the Open with You Are Loved, the first installment focused on chemsex LONDON–(BUSINESS WIRE)–$GRND—Grindr for Equality, the global social impact initiative of Grindr, the world’s largest social networking app for gay, bi, trans, and queer people, launches Out in the Open, a new content series that does what Grindr … [Read more…]

Offering is being led by HeartBeam’s first commercial customer, ClearCardio™, the Company’s executive leadership, board members, and existing investors SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the pricing of its underwritten public offering of 12,500,000 shares of its common … [Read more…]